Human Endothelial Progenitor Cell

Human endothelial progenitor cells (EPCs) are circulating cells that exhibit a range of cell surface markers comparable to those found on vascular endothelial cells. They encompass primitive endothelial cells that possess enhanced angiogenic and vasculogenic characteristics. These primitive endothelial cells have the remarkable capacity to proliferate and undergo differentiation, ultimately maturing into functional endothelial cells.

Human Endothelial Progenitor Cell from Ace Therapeutics can be expanded for up to 120 population doublings or 12 passages, providing ample material for experimentation. They express positive markers such as CD31, CD144, (VEGF)R2, CD146, CD73, CD105, and exhibit the uptake of acetylated low-density lipoprotein. Furthermore, AcceGen provides one million viable cells upon thawing of the frozen vial, which is shipped in dry ice to maintain cell integrity during transportation.

• Supplier: Ace Therapeutics
• Product #: BBM-C-175
• Product Category: Stem Cells
• Species: Human
• Citation Guidance: If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards.
• Source: Endothelial
• Recommended Medium: It is recommended to use Human Endothelial Progenitor Cell Medium Kit for culturing in vitro.
• Cell Type: Stem Cell
• Disease: Normal
• Quality Control: Human Endothelial Progenitor Cell test negative for bacteria, yeast, fungi, and mycoplasma.
• Shipping and Storage:
  • Ace Therapeutics ships frozen cells using dry ice. Upon receiving the frozen cells, immediately move them into liquid nitrogen (-180 °C) for storage.
  • Note: Never can cells be kept at -20 °C, and repeated freezing and thawing of cells is not recommended.